GCM
MDT icon

Garland Capital Management’s Medtronic MDT Stock Holding History

Garland Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$284K Sell
2,980
-8,735
-75% -$803K 3.9% 15
2025
Q2 		$1.02M Sell
11,715
-26,910
-70% -$2.28M 3.24% 16
2025
Q1 		$3.47M Sell
38,625
-2,850
-7% -$255K 3.25% 17
2024
Q4 		$3.31M Sell
41,475
-375
-0.9% -$32.5K 2.72% 21
2024
Q3 		$3.77M Sell
41,850
-4,180
-9% -$352K 2.9% 20
2024
Q2 		$3.62M Buy
46,030
+1,355
+3% +$111K 2.56% 25
2024
Q1 		$3.89M Sell
44,675
-315
-0.7% -$26.9K 2.58% 25
2023
Q4 		$3.71M Sell
44,990
-1,170
-3% -$89.2K 2.6% 24
2023
Q3 		$3.62M Buy
46,160
+710
+2% +$59.4K 2.55% 23
2023
Q2 		$4M Buy
45,450
+2,375
+6% +$204K 2.69% 22
2023
Q1 		$3.47M Buy
+43,075
New +$3.51M 2.36% 28

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Garland Capital Management's MDT Position: Q3 2025 in Review

Garland Capital Management reduced its Medtronic (MDT) stake by 75% in Q3 2025, selling an estimated $803K and leaving 2,980 shares worth $284K. The position accounts for 3.9% of the portfolio, ranked #15.

Garland Capital Management first reported a position in MDT in Q1 2023 and has held it in 11 quarters since. The position peaked at $4M in Q2 2023. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Garland Capital Management held 2,980 shares of Medtronic worth $284K as of Q3 2025.
  • Garland Capital Management sold 8,735 Medtronic shares in Q3 2025, an estimated $803K.
  • Medtronic made up 3.9% of Garland Capital Management's portfolio in Q3 2025, its #15 holding.
  • Garland Capital Management first reported a position in Medtronic in Q1 2023 and has held it in 11 quarters since.
  • Garland Capital Management's Medtronic position peaked at $4M in Q2 2023.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Garland Capital Management's 13F filing for Q3 2025, filed 5 Nov 2025.